Avoro Capital Advisors LLC lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 65.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,222,222 shares of the company’s stock after acquiring an additional 1,666,667 shares during the quarter. Syndax Pharmaceuticals comprises approximately 1.3% of Avoro Capital Advisors LLC’s portfolio, making […]
Crestline Management LP decreased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 25.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 100,649 shares of the company’s stock after selling 33,815 shares during the quarter. Crestline Management LP owned […]